Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Appointed director
Quarterly results
Consulting agrmnt
ClearPoint Neuro, Inc. (CLPT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "ClearPoint Neuro Reports Second Quarter 2023 Results",
"2 0 2 3 C L E A R P O I N T N E U R O 2"
08/01/2023 8-K Quarterly results
05/25/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "CERTIFICATE OF AMENDMENT OF CLEARPOINT NEURO, INC."
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Quarterly results
Docs: "ClearPoint Neuro Reports First Quarter 2023 Results",
"2 0 2 3 C L E A R P O I N T N E U R O 2"
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/03/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/01/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Quarterly results
Docs: "ClearPoint Neuro Reports Fourth Quarter and Full-Year 2022 Results"
02/09/2023 SC 13G/A BIGGER CAPITAL FUND L P reports a 5.5% stake in ClearPoint Neuro, Inc.
01/30/2023 5 STIGALL L. JEREMY (GM, Biologics & Drug Delivery) has filed a Form 5 on ClearPoint Neuro, Inc.
01/30/2023 5 D'Alessandro Danilo (CFO) has filed a Form 5 on ClearPoint Neuro, Inc.
01/11/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "ClearPoint Neuro Reports Fourth Quarter and Full Year 2022 Preliminary Revenue Results and Guidance for Full Year 2023 Revenue",
"2 0 2 3 C L E A R P O I N T N E U R O 2"
12/14/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
Docs: "ClearPoint Neuro Reports Third Quarter 2022 Results",
"2 0 2 2 C L E A R P O I N T N E U R O 2"
11/07/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "DO NOT USE THIS FORM FOR MULTI-TENANT"
09/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "EMPLOYMENT AGREEMENT THIS AGREEMENT",
"ClearPoint Neuro Announces Appointment of Mazin Sabra as Chief Operating Officer"
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: "ClearPoint Neuro Reports Second Quarter 2022 Results",
"2 0 2 2 C L E A R P O I N T N E U R O 2"
06/06/2022 8-K Quarterly results
06/01/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/26/2022 8-K Quarterly results
05/23/2022 8-K Quarterly results
05/19/2022 8-K Quarterly results
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/11/2022 8-K Quarterly results
04/11/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/08/2022 10-K Annual Report for the period ended December 31, 2021
03/01/2022 8-K Quarterly results
02/15/2022 8-K Investor presentation
Docs: "ClearPoint Neuro Reports Fourth Quarter and Full Year 2021 Preliminary Revenue Results and Guidance for Full Year 2022 Revenue Company to Hold Earnings Call on March 1, 2022",
"Investor Presentation dated February 2022"
02/14/2022 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Confidential Resignation Agreement, by and between the Company and Peter G. Piferi",
"Confidential Resignation Agreement, by and between the Company and Peter G. Piferi"
01/25/2022 SC 13G/A BIGGER CAPITAL FUND L P reports a 5.2% stake in ClearPoint Neuro, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy